Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study. (2017)

First Author: Whittles LK

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1002416

PubMed Identifier: 29088226

Publication URI: http://europepmc.org/abstract/MED/29088226

Type: Journal Article/Review

Volume: 14

Parent Publication: PLoS medicine

Issue: 10

ISSN: 1549-1277